Press Releases & Statements

Investor Relations

Month Year

Month Year

Novavax to Host Conference Call to Discuss Fourth Quarter Financial Results and Operational Highlights on March 1, 2021
- Corporate and Finance
Feb 16, 2021
Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea
- COVID-19
Feb 15, 2021
Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization
- COVID-19
Feb 4, 2021
Novavax and Government of Switzerland Announce Agreement in Principle to Supply COVID-19 Vaccine
- COVID-19
Feb 3, 2021
Novavax Announces Memorandum of Understanding to Produce COVID-19 Vaccine Made in Canada
- COVID-19
Feb 2, 2021
Novavax to Present COVID-19 Vaccine Candidate Data at New York Academy of Science
- COVID-19
Feb 1, 2021
Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial
- COVID-19
Jan 28, 2021
Novavax Names Madelyn Caltabiano Senior Vice President, Global Program Management
- Corporate and Finance
Jan 22, 2021
Novavax and Government of Canada Finalize Advance Purchase Agreement for COVID-19 Vaccine
- COVID-19
Jan 22, 2021
Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
- Corporate and Finance
Jan 15, 2021

Show per page